Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR)

CUSIP: 49372L100

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 5 signals
Share change
+1
SEC-reported price per share
$1.00
Number of holders
1
Value change
+$1
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,393,623

Security key

49372L100

Report period

Q3 2025

Institutions

1

Top holders

0

Ownership snapshot

Top reported holders of KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Equal Talent Investments Ltd
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 8.7% 13D/G row: Equal Talent Investments Ltd Showing 1-6 of 15 holder rows.

Quick read

Equal Talent Investments Ltd leads the comparable SEC ownership view at 8.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Equal Talent Investments Ltd's linked filing trail.
Comparable ownership Top 5
Equal Talent Investments Ltd 8.7%
TANG CAPITAL MANAGEMENT LLC 9.7%
SUVRETTA CAPITAL MANAGEMENT, LLC 9.6%
BML Capital Management, LLC 8.5%
Avidity Partners Management LP 6.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Equal Talent Investments Ltd
13D/G
Equal Talent Investments Limited
8.7%
$487,037
616,502 shares
$0 28 Feb 2025
TANG CAPITAL MANAGEMENT LLC
13F
Company
13F
9.7%
$3,297,600
720,000 shares
30 Jun 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
9.6%
$3,282,756
716,759 shares
30 Jun 2025
BML Capital Management, LLC
13F
Company
13F
8.5%
$2,909,138
635,183 shares
30 Jun 2025
Avidity Partners Management LP
13F
Company
13F
6.8%
$2,301,908
502,600 shares
30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
3.7%
$1,265,124
276,228 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .